WilmerHale Advises Underwriters in $36.4M Cerecor Inc. Offering
WilmerHale represented the underwriters in the public offering of 12,323,077 shares of common stock of Cerecor Inc., a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, at a public offering price per share of $2.60. In addition, and in lieu of common stock, the company offered to a certain existing investor pre-funded warrants to purchase up to an aggregate of 1,676,923 shares of common stock at a purchase price of $2.599 per pre-funded warrant. The gross proceeds to the company were $36.4 million, before deducting underwriting discounts and offering expenses. The offering priced on January 7, 2021 and closed on January 12, 2021.
The WilmerHale team advising the underwriters consisted of
Lisa Firenze,
Bruce Manheim,
Colleen Superko,
Chip McCorkle and
Gerard Fischetti.
